EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS SCISCIE

中文简介

《欧洲药学和生物药理学杂志》提供了一个出版来自制药技术、制药生物技术和生物药理学领域的新颖和创新研究的媒体。主题包括:?药物和药物前设计、药物稳定性和药物开发?药物和生物制药的开发、配方和制造?物理制药、药物传递系统、控制释放系统和药物靶向?生物药剂学?药物分析和药物包装?质量控制、GMP和法规方面?医疗设备“三的规则”编辑和编辑委员会制定了“3的规则”。在投稿前，作者必须考虑以下三个标准，并在工作中设定完整的编辑审核流程:1. 这篇论文必须报道在制药技术、生物制药和重要的制药生物技术方面的最新进展2. 一篇论文必须基于深入和广泛的研究，使用已建立的或描述良好的方法，包括适当的控制。研究必须是假设驱动的，结论必须得到数据的支持。3.手稿中描述的研究必须代表一种新颖的方法这些规则也被用作同行审稿的指导方针。请按此浏览“规则三”

投稿网址：http://ees.elsevier.com/ejpb/

英文简介

The European Journal of Pharmaceutics and Biopharmaceutics provides a medium for publication of novel and innovative research from the areas of Pharmaceutical Technology, Pharmaceutical Biotechnology and Biopharmaceutics.Topics covered include:? Drug and pro-drug design, drug stability and drug development? Development, formulation and manufacturing of pharmaceuticals and biopharmaceuticals? Physical pharmacy, drug delivery systems, controlled release systems and drug targeting? Biopharmaceutics? Pharmaceutical analysis and pharmaceutical packaging? Quality control, GMP and regulatory aspects? Medical devices"The Rules of 3"The Editors and Editorial board have developed the "Rules of 3". Authors must consider the following three criteria before they submit a manuscript and set the whole process of editing and reviewing at work:1. The paper must report on recent advances in pharmaceutical technology, biopharmaceutics and pharmaceutical biotechnology of major importance2. A paper must be based on a thorough and extensive study, using established or well-described methods and including proper controls. Research must be hypothesis-driven and conclusions must be supported by the data presented.3. The study described in the manuscript must represent a novel approachThe rules are also used as guidelines for the peer review of manuscripts. CLICK HERE to view the "Rules of 3".